These outcomes, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a unique strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Problems. Increase more healthy immune function: https://steelem905fwm1.blogcudinti.com/profile